Amgen (AMGN) Dividends Paid - Common (2011 - 2026)

Amgen (AMGN) recorded quarterly Dividends Paid - Common of $1.4 billion in Q1 2026, up 5.85% quarter-over-quarter from $1.3 billion in Q4 2025, and up 6.18% on a YoY basis from $1.3 billion in Q1 2025.

Amgen (AMGN) Dividends Paid - Common (2011 - 2026) Analysis & Trends

Amgen's Dividends Paid - Common history runs 16 years deep, the most recent figure standing at $1.4 billion for Q1 2026.

  • In Q1 2026, Dividends Paid - Common rose 6.18% year-over-year to $1.4 billion; the TTM figure through Mar 2026 stood at $5.2 billion (up 6.12% YoY), while the FY2025 annual figure was $5.1 billion, up 6.04% from the prior year.
  • Dividends Paid - Common was $1.4 billion for Q1 2026 at Amgen, up from $1.3 billion in the prior quarter.
  • In the past five years, Dividends Paid - Common ranged from a high of $1.4 billion in Q1 2026 to a low of $1.0 billion in Q2 2022.
  • Historically, Dividends Paid - Common has averaged $1.2 billion across 5 years, with a median of $1.2 billion in 2024.
  • The sharpest annual moves came in 2022 and 2023: Dividends Paid - Common gained 2.98% in 2022, then gained 9.83% in 2023.
  • A 5-year view of Dividends Paid - Common shows it stood at $1.0 billion in 2022, then grew by 9.62% to $1.1 billion in 2023, then increased by 5.7% to $1.2 billion in 2024, then gained by 6.47% to $1.3 billion in 2025, then increased by 5.85% to $1.4 billion in 2026.
  • The last three Dividends Paid - Common figures came in at $1.4 billion (Q1 2026), $1.3 billion (Q4 2025), and $1.3 billion (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dividends Paid - Common (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn -866.88 Mn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn 1.55 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn 3.13 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn 3.09 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn 2.11 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn 1.36 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn 1.04 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn 2.45 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn 1.28 Bn
10 Novartis Ag 109.78 Bn 109.09 Bn - -

Historic Data

Download Data
DateValue
Mar 31, 2026 1.36 Bn
Mar 31, 2026 1.36 Bn
Dec 31, 2025 1.28 Bn
Dec 31, 2025 1.28 Bn
Sep 30, 2025 1.28 Bn
Sep 30, 2025 1.28 Bn
Jun 30, 2025 1.28 Bn
Jun 30, 2025 1.28 Bn
Mar 31, 2025 1.28 Bn
Mar 31, 2025 1.28 Bn
Dec 31, 2024 1.21 Bn
Dec 31, 2024 1.21 Bn
Sep 30, 2024 1.21 Bn
Sep 30, 2024 1.21 Bn
Jun 30, 2024 1.21 Bn
Jun 30, 2024 1.21 Bn
Mar 31, 2024 1.21 Bn
Mar 31, 2024 1.21 Bn
Dec 31, 2023 1.14 Bn
Dec 31, 2023 1.14 Bn